Fan Y, Huang S, Li F, Zhang X, Huang X, Li W
J Mol Neurosci. 2024; 74(1):19.
PMID: 38358571
DOI: 10.1007/s12031-024-02196-5.
Kembuan G, Kim J, Maus M, Jan M
Trends Cancer. 2024; 10(4):312-331.
PMID: 38355356
PMC: 11006585.
DOI: 10.1016/j.trecan.2024.01.003.
Machy P, Mortier E, Birkle S
Front Pharmacol. 2023; 14:1249929.
PMID: 37670947
PMC: 10475612.
DOI: 10.3389/fphar.2023.1249929.
Jeremiasse B, Rijs Z, Angoelal K, Hiemcke-Jiwa L, de Boed E, Kuppen P
Cancers (Basel). 2023; 15(15).
PMID: 37568714
PMC: 10417270.
DOI: 10.3390/cancers15153896.
Pilgrim A, Jonus H, Ho A, Cole A, Shim J, Goldsmith K
Oncoimmunology. 2023; 12(1):2240678.
PMID: 37554309
PMC: 10405770.
DOI: 10.1080/2162402X.2023.2240678.
Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation.
El Malki K, Wehling P, Alt F, Sandhoff R, Zahnreich S, Ustjanzew A
Int J Mol Sci. 2023; 24(12).
PMID: 37373053
PMC: 10298524.
DOI: 10.3390/ijms24129905.
GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype.
Paret C, Ustjanzew A, Ersali S, Seidmann L, Jennemann R, Ziegler N
Cancers (Basel). 2022; 14(24).
PMID: 36551537
PMC: 9775636.
DOI: 10.3390/cancers14246051.
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs.
Ciaccio R, De Rosa P, Aloisi S, Viggiano M, Cimadom L, Zadran S
Int J Mol Sci. 2021; 22(23).
PMID: 34884690
PMC: 8657550.
DOI: 10.3390/ijms222312883.
Exploiting Gangliosides for the Therapy of Ewing's Sarcoma and H3K27M-Mutant Diffuse Midline Glioma.
Wingerter A, El Malki K, Sandhoff R, Seidmann L, Wagner D, Lehmann N
Cancers (Basel). 2021; 13(3).
PMID: 33572900
PMC: 7866294.
DOI: 10.3390/cancers13030520.
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.
Nazha B, Inal C, Owonikoko T
Front Oncol. 2020; 10:1000.
PMID: 32733795
PMC: 7358363.
DOI: 10.3389/fonc.2020.01000.
The ganglioside G as a circulating tumor biomarker for neuroblastoma.
Balis F, Busch C, Desai A, Hibbitts E, Naranjo A, Bagatell R
Pediatr Blood Cancer. 2019; 67(1):e28031.
PMID: 31612589
PMC: 7863579.
DOI: 10.1002/pbc.28031.
Dynamics of Minimal Residual Disease in Neuroblastoma Patients.
Uemura S, Ishida T, Mon Thwin K, Yamamoto N, Tamura A, Kishimoto K
Front Oncol. 2019; 9:455.
PMID: 31214500
PMC: 6558004.
DOI: 10.3389/fonc.2019.00455.
Positron Emission Tomography Detects Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma.
Butch E, Mead P, Amador Diaz V, Tillman H, Stewart E, Mishra J
Cancer Res. 2019; 79(12):3112-3124.
PMID: 31015228
PMC: 6571039.
DOI: 10.1158/0008-5472.CAN-18-3340.
GD2 expression in breast cancer.
Orsi G, Barbolini M, Ficarra G, Tazzioli G, Manni P, Petrachi T
Oncotarget. 2017; 8(19):31592-31600.
PMID: 28415563
PMC: 5458232.
DOI: 10.18632/oncotarget.16363.
Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells.
Carpenter E, Rader J, Ruden J, Rappaport E, Hunter K, Hallberg P
Front Oncol. 2014; 4:201.
PMID: 25133137
PMC: 4116800.
DOI: 10.3389/fonc.2014.00201.
Generation of murine sympathoadrenergic progenitor-like cells from embryonic stem cells and postnatal adrenal glands.
Saxena S, Wahl J, Huber-Lang M, Stadel D, Braubach P, Debatin K
PLoS One. 2013; 8(5):e64454.
PMID: 23675538
PMC: 3651195.
DOI: 10.1371/journal.pone.0064454.
Distinct morphological and immunohistochemical features and different growth rates among four human neuroblastomas heterotransplanted into nude mice.
Hoshi N, Hitomi J, Kusakabe T, Fukuda T, Hirota M, Suzuki T
Med Mol Morphol. 2008; 41(3):151-9.
PMID: 18807141
DOI: 10.1007/s00795-008-0407-x.
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule.
Gregorio A, Corrias M, Castriconi R, Dondero A, Mosconi M, Gambini C
Histopathology. 2008; 53(1):73-80.
PMID: 18613926
PMC: 2658025.
DOI: 10.1111/j.1365-2559.2008.03070.x.
Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
Wondimu A, Zhang T, Kieber-Emmons T, Gimotty P, Sproesser K, Somasundaram R
Cancer Immunol Immunother. 2007; 57(7):1079-89.
PMID: 18157673
PMC: 3426288.
DOI: 10.1007/s00262-007-0439-4.
Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow.
Swerts K, Ambros P, Brouzes C, Navarro J, Gross N, Rampling D
J Histochem Cytochem. 2005; 53(12):1433-40.
PMID: 15956022
PMC: 3957549.
DOI: 10.1369/jhc.5C6661.2005.